04. June 2026

OPPENLÄNDER is strengthening its Intellectual Property and Healthcare practice with the addition of attorney Dr. Sonja Bühler, LL.M. (Edinburgh)

Dr. Sonja Bühler joined our Intellectual Property and Healthcare team in June 2026.

Sonja Bühler studied law at the Universities of Freiburg im Breisgau and Glasgow (Scotland). She specialized in intellectual property law early on with her master’s degree in the field of intellectual property law at the University of Edinburgh (Scotland). Her doctoral thesis under Prof. Haedicke in Freiburg focused on a topic in patent and pharmaceutical law. After completing her legal clerkship at the Dresden Higher Regional Court, she gained professional experience in the legal department of a universal bank, focusing on digitalization, before joining OPPENLÄNDER in 2026.

Dr. Sonja Bühler

+49 (0)711 60187-177
sonja.buehler@oppenlaender.de

Dr. Timo Kieser

+49 (0)711 60187-230
kieser@oppenlaender.de

More news

All news

01. July 2026

EUWA advised on sale to Grundfos by OPPENLÄNDER Rechtsanwälte

The shareholder of Germany-based water treatment specialist EUWA was advised by OPPENLÄNDER Rechtsanwälte on corporate law matters and in connection with the M&A transaction relating to the sale of his shares to Danish pump and water technology group Grundfos.

18. June 2026

Handelsblatt and Best Lawyers Once Again Recognize OPPENLÄNDER

Our lawyers are among the Best Lawyers. The U.S. publisher identified the best lawyers in the DACH region for the year 2026 on behalf of Handelsblatt. The awards are based on surveys of industry peers and highlight those who stand out for their professional qualifications, strong reputation, and excellent market position.

22. May 2026

OPPENLÄNDER defends against state liability claims against the state of Baden-Württemberg

In its ruling dated May 20, 2026 (Case No. 4 U 168/25), the Stuttgart Higher Regional Court dismissed the appeal filed by a major non-food retail group against the State of Baden-Württemberg, thereby upholding the Stuttgart Regional Court’s ruling dismissing the claim. The plaintiff had asserted claims for compensation due to the business closures ordered […]

13. May 2026

OPPENLÄNDER wins lawsuit regarding claims for damages arising from pharmaceutical rebate contracts

Dr Matthias Ulshöfer and Dr Joachim Ott have successfully defended an international pharmaceutical company against unjustified claims for damages arising from pharmaceutical rebate contracts in a landmark case before the Munich Social Court. The actions brought by a major statutory health insurance fund were dismissed by way of a “judgment from the bench”.